Thraustochytrid Fermentation for EPA-Rich Biomass via CO2 Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing thraustochytrid microorganisms vary in omega-3 fatty acid production, particularly eicosapentaenoic acid (EPA) levels, leading to undesirable profiles and low productivity in fermentation processes, necessitating the development of methods to modulate EPA and docosahexaenoic acid (DHA) concentrations.

Innovation Solution

Adjusting fermentation conditions such as dissolved carbon dioxide (CO2) levels, pressure, temperature, and nutrient composition, specifically reducing vitamin B12 and cobalt in the culture medium, to enhance EPA production in Thraustochytrid microorganisms, achieving biomass with at least 3% EPA by weight.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional fermentation methods are used with thraustochytrid microorganisms, then productivity is maintained at standard levels, but EPA concentration in biomass remains low with undesirable fatty acid profiles

Engineering Contradiction:
ImproveEPA concentrationVSAvoidfermentation productivity
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent applies parameter changes by modifying dissolved CO2 levels (increasing to 5-20% or higher), adjusting temperature (15-30°C ranges), and controlling nutrient composition (reducing vitamin B12 and cobalt) to shift the fermentation process toward high EPA production. These parameter modifications transform the fatty acid profile to achieve ≥3% EPA while maintaining productivity.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If dissolved CO2 levels are increased to modulate EPA production, then EPA concentration increases significantly, but fermentation process complexity increases

Engineering Contradiction:
ImproveEPA concentrationVSAvoidfermentation process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent implements parameter changes by controlling dissolved CO2 levels as a primary lever to modulate EPA production. This approach uses a single controllable parameter (CO2 dissolution) to achieve the desired fatty acid profile modification without requiring complex multi-component interventions, thereby managing process complexity while achieving high EPA concentrations.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If vitamin B12 and cobalt are reduced in culture medium to enhance EPA production, then EPA concentration increases, but microorganism growth may be affected

Engineering Contradiction:
ImproveEPA concentrationVSAvoidmicroorganism growth stability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies parameter changes by optimizing nutrient composition, specifically reducing vitamin B12 and cobalt levels in the culture medium. This modification creates metabolic conditions that favor EPA accumulation while the overall nutrient balance and fermentation parameters are adjusted to maintain reliable microorganism growth and productivity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Significantly increases EPA concentration in the biomass by up to 700% compared to conventional methods, resulting in a more efficient and controlled production of omega-3 fatty acids.

Implementation Method 1

fermenting the microorganism in a fermentor vessel having a dissolved gas in a fermentation broth to produce a biomass

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentEP4585049A2Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
Publication Date: 2025.07.16 DSM IP ASSETS BV
  • EP4585049A2 patent drawingFigure 1~2
  • EP4585049A2 patent drawingFigure 3~4
  • EP4585049A2 patent drawingFigure 5~6

AI summary

The present invention is directed to isolated microorganisms as well as strains and mutants thereof, biomasses, microbial oils, compositions, and cultures; methods of producing the microbial oils, biomasses, and mutants; and methods of using the isolated microorganisms, biomasses, and microbial oils.